APA

Pennell A. M. K., Aggen J. B., Sen S., Chen W., Xu Y., Sullivan E., Li L., Greenman K., Charvat T., Hansen D., Dairaghi D. J., Wright J. J. K. & Zhang P. (20140113). 1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonists. : Bioorganic & medicinal chemistry letters.

Chicago

Pennell Andrew M K, Aggen James B, Sen Subhabrata, Chen Wei, Xu Yuan, Sullivan Edward, Li Lianfa, Greenman Kevin, Charvat Trevor, Hansen Derek, Dairaghi Daniel J, Wright J J Kim and Zhang Penglie. 20140113. 1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonists. : Bioorganic & medicinal chemistry letters.

Harvard

Pennell A. M. K., Aggen J. B., Sen S., Chen W., Xu Y., Sullivan E., Li L., Greenman K., Charvat T., Hansen D., Dairaghi D. J., Wright J. J. K. and Zhang P. (20140113). 1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonists. : Bioorganic & medicinal chemistry letters.

MLA

Pennell Andrew M K, Aggen James B, Sen Subhabrata, Chen Wei, Xu Yuan, Sullivan Edward, Li Lianfa, Greenman Kevin, Charvat Trevor, Hansen Derek, Dairaghi Daniel J, Wright J J Kim and Zhang Penglie. 1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonists. : Bioorganic & medicinal chemistry letters. 20140113.